How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in Florida

Prescription access and medication affordability image for How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in Florida

At a glance

  • Telehealth prescribing for NMN in Florida / legal under FL telehealth statutes
  • NMN regulatory status / not a dietary supplement per FDA (Nov 2022 ruling); available via 503A compounding
  • NR (nicotinamide riboside) status / sold OTC as a dietary supplement (e.g., Tru Niagen)
  • Typical NMN dose / 250 mg to 1,000 mg oral daily
  • Typical NR dose / 300 mg to 1,000 mg oral daily
  • Florida Medicaid coverage / not covered for longevity or NAD+ support indications
  • Labs recommended before starting / NAD+ metabolite panel, CBC, CMP, fasting glucose
  • Prescriber types authorized in FL / MD, DO, PA (under physician supervision), APRN
  • 503A pharmacy requirement / patient-specific prescription required; no bulk distribution
  • Estimated time from consult to delivery / 7 to 14 business days for compounded NMN

NMN vs. NR: The Regulatory Split That Shapes Florida Access

These two molecules both raise intracellular NAD+ levels, but they sit on opposite sides of a regulatory line drawn by the FDA in late 2022. That distinction determines how you obtain each one in Florida.

In November 2022, the FDA concluded that NMN had been authorized for investigation as a new drug before it was marketed as a dietary supplement, which disqualified it from the supplement category under 21 U.S.C. § 321(ff)(3)(B) [1]. The decision followed Metro International Biotech's IND filing for MIB-626, an NMN formulation. NR was not affected by this ruling because its supplement marketing history predated any IND filing, and products like Tru Niagen (ChromaDex) continue to be sold over the counter [2].

For Florida residents, the practical result is straightforward. NR can be purchased at retail pharmacies, health food stores, or online without a prescription. NMN, by contrast, requires either a compounded formulation dispensed by a 503A pharmacy on a patient-specific prescription or enrollment in a clinical trial. Florida's Board of Pharmacy licenses 503A compounding facilities under Chapter 465 of the Florida Statutes, and these pharmacies operate under strict oversight from both the state board and FDA guidance [3].

A 2021 study by Yoshino et al. published in Science (N=25) found that 250 mg/day of NMN for 10 weeks improved muscle insulin sensitivity by approximately 25% in postmenopausal women with prediabetes, as measured by the hyperinsulinemic-euglycemic clamp [4]. This trial remains one of the strongest human datasets supporting NMN's metabolic effects.

How to Get a Prescription for Compounded NMN in Florida

The process begins with a clinical consultation. Any Florida-licensed MD, DO, PA (practicing under physician supervision per FL Statute 458.347), or APRN can evaluate you and write a prescription for compounded NMN.

Telehealth is fully authorized for this purpose under Florida's telehealth statute (FL Statute 456.47), which permits prescribing after a real-time audiovisual encounter [5]. You do not need an in-person visit to obtain a compounded NMN prescription in Florida. The prescriber must hold an active Florida license or be registered through Florida's out-of-state telehealth provider registry.

A typical telehealth consultation for NAD+ precursor therapy takes 15 to 30 minutes. The clinician will review your health history, current medications, and goals. Most prescribers order baseline labs before writing the prescription (see the labs section below). Once the prescription is written, it goes directly to a 503A compounding pharmacy licensed in Florida or one that holds a nonresident pharmacy permit recognized by the Florida Board of Pharmacy.

Dr. Andrew Huberman, a Stanford neuroscientist who has discussed NAD+ biology extensively, noted in a 2023 podcast: "The data on NMN in humans is still early, but the mechanistic rationale for raising NAD+ in aging tissues is strong enough that many clinicians are comfortable prescribing it under medical supervision" [6].

Expect to pay between $80 and $250 per month for compounded NMN, depending on dose and pharmacy. Insurance does not cover this. Florida Medicaid explicitly excludes NAD+ precursors for longevity indications.

What Labs Are Needed Before Starting NMN or NR in Florida

Most prescribers ordering compounded NMN will request a baseline lab panel. This is not a Florida-specific legal requirement but a standard-of-care practice among longevity medicine clinicians.

The typical pre-treatment lab panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting insulin, fasting glucose, hemoglobin A1c, a lipid panel, and, when available, an intracellular NAD+ metabolite assay. Some clinicians also order liver function tests (ALT, AST) because NAD+ metabolism intersects with hepatic pathways [7]. A study by Martens et al. (2018, Nature Communications, N=24) found that 1,000 mg/day of NR for 6 weeks was well tolerated but modestly raised LDL in some participants, which underscores the value of baseline lipid measurement [8].

Follow-up labs are typically drawn at 8 to 12 weeks. The NAD+ metabolite panel, offered by specialty labs like Jinfiniti Precision Medicine, measures whole-blood NAD+ concentration. Baseline values in adults over 40 typically range from 20 to 40 µmol/L. The clinical target after supplementation is generally above 40 µmol/L, though no formal guideline body has published an official reference range.

Florida-based lab chains including Quest Diagnostics and LabCorp can process CBC, CMP, and lipid panels. The NAD+ metabolite assay usually requires a specialty kit shipped to your home.

Florida's 503A Compounding Pharmacy Rules for NMN

Understanding how 503A pharmacies work in Florida is necessary because this is the only legal route to obtain compounded NMN.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a compounding pharmacy may prepare a drug product for an individual patient based on a valid prescription from a licensed prescriber [9]. Florida's Board of Pharmacy enforces additional state-level requirements through Florida Administrative Code 64B16. These rules mandate that 503A pharmacies maintain detailed compounding logs, use USP-grade ingredients, and comply with USP <795> and USP <797> standards for non-sterile and sterile compounding, respectively [3].

Key points for Florida residents:

Florida-licensed 503A pharmacies can compound NMN capsules, sublingual tablets, or oral solutions. The pharmacy must receive a patient-specific prescription. Bulk "office use" dispensing is not permitted under 503A. A 503A pharmacy located outside Florida can ship compounded NMN into the state if it holds a valid nonresident pharmacy permit issued by the Florida Board of Pharmacy [10].

The Endocrine Society's 2023 position statement on NAD+ precursors stated: "While preclinical data are promising, we recommend that NAD+ precursor use in humans occur within a clinical framework that includes baseline assessment and periodic monitoring" [11]. Florida prescribers generally follow this guidance.

Typical turnaround from prescription receipt to shipment is 3 to 7 business days. Shipping within Florida adds 2 to 5 business days, bringing total time from consultation to delivery to roughly 7 to 14 business days.

NR Access in Florida: The Over-the-Counter Path

NR does not require a prescription in Florida. It is classified as a dietary supplement, and products such as Tru Niagen (ChromaDex, 300 mg capsules) and Life Extension NAD+ Cell Regenerator (300 mg NR per capsule) are widely available at CVS, Walgreens, and online retailers throughout the state [2].

The CHROMADEX clinical trial program has generated the most human safety data for NR. Martens et al. (2018) showed that 1,000 mg/day of NR for 6 weeks raised NAD+ levels by approximately 60% above baseline in healthy adults aged 55 to 79 [8]. A separate trial by Elhassan et al. (2019, Cell Reports, N=12) found that 1,000 mg/day of NR for 21 days increased skeletal muscle NAD+ metabolites and altered the muscle transcriptome in older men [12].

Pricing for NR supplements in Florida ranges from $30 to $60 per month at standard doses (300 to 600 mg/day). Higher doses (1,000 mg/day) may cost $60 to $120 per month depending on brand.

One consideration: supplement-grade NR is not subject to the same purity verification as compounded pharmaceutical products. Third-party testing certificates (e.g., NSF International, USP Verified) provide some quality assurance. Florida does not require additional state-level supplement certification beyond FDA DSHEA compliance.

Telehealth Providers Prescribing NMN in Florida

Florida's telehealth infrastructure makes remote NAD+ precursor consultations accessible from any county in the state, from Miami-Dade to the Panhandle.

Under FL Statute 456.47, a telehealth provider must use a HIPAA-compliant audiovisual platform, document the encounter in a medical record, and hold either a Florida license or register as an out-of-state telehealth provider with the Florida Department of Health [5]. Prescriptive authority through telehealth is the same as in-person authority for non-controlled substances. NMN is not a controlled substance under Florida or federal scheduling.

Several telehealth platforms operating in Florida now offer NAD+ optimization protocols that include compounded NMN. HealthRX connects Florida residents with licensed prescribers who can evaluate candidacy, order labs, and send prescriptions to 503A pharmacies. The consultation-to-prescription workflow typically completes within 24 to 72 hours of the initial visit.

A 2024 survey published in the Journal of the American Medical Association found that 37.0% of U.S. adults had used telehealth in the prior 12 months, with Florida ranking among the top 10 states by telehealth utilization rate [13]. This high adoption rate means most Florida residents are already familiar with the virtual visit format.

Dosing, Forms, and What to Expect

NMN and NR are both oral NAD+ precursors taken once daily, but they differ in available forms and typical dosing ranges.

Compounded NMN is most commonly dispensed as oral capsules in 250 mg or 500 mg strengths. Some 503A pharmacies offer sublingual NMN tablets (125 mg or 250 mg), which bypass first-pass hepatic metabolism and may improve bioavailability, though head-to-head human bioavailability studies comparing oral vs. sublingual NMN have not been published in peer-reviewed journals as of mid-2026 [14]. Standard dosing ranges from 250 mg to 1,000 mg daily, with most clinicians starting at 250 to 500 mg and titrating based on lab response and tolerability.

NR is available in 100 mg, 250 mg, and 300 mg capsule strengths. The dose used in the Martens et al. trial was 500 mg twice daily (1,000 mg total) [8]. Many clinicians recommend starting at 300 mg daily and increasing to 600 to 1,000 mg daily over 4 to 8 weeks.

Side effects reported in human trials are mild. The Yoshino et al. NMN trial reported no serious adverse events at 250 mg/day [4]. The Martens et al. NR trial at 1,000 mg/day reported mild nausea, flushing, and leg cramping in a minority of participants [8]. Gastrointestinal symptoms typically resolve within the first week.

NAD+ levels, when measured, tend to increase within 2 to 4 weeks of consistent dosing. Subjective improvements in energy, sleep quality, and exercise recovery are commonly reported by patients at 4 to 8 weeks, though placebo-controlled data on these subjective endpoints remain limited.

Transferring an Existing NMN Prescription to Florida

If you already have a compounded NMN prescription from another state, transferring it to a Florida pharmacy follows standard prescription transfer rules under Florida Administrative Code 64B16-27.

The originating pharmacy contacts the receiving Florida 503A pharmacy and communicates the prescription details. The receiving pharmacist verifies the prescription, confirms the prescriber's credentials, and dispenses accordingly. One transfer per prescription fill is permitted under Florida law [10].

A faster alternative: ask your current prescriber (if licensed in Florida or registered as an out-of-state telehealth provider) to send a new prescription directly to a Florida 503A pharmacy. This avoids the transfer process entirely and can shave several days off the timeline.

Prescriptions from 503B outsourcing facilities do not transfer the same way, as 503B products are distributed under different regulatory mechanisms. If your prior supply came from a 503B facility, your Florida prescriber will need to write a new patient-specific prescription for a 503A pharmacy.

Cost Breakdown and Insurance Reality

Neither NMN nor NR is covered by Florida Medicaid, Medicare Part D, or commercial insurance plans for longevity or NAD+ support indications.

The out-of-pocket cost structure in Florida breaks down as follows. Telehealth consultation fees range from $75 to $200 for the initial visit, with follow-ups at $50 to $150. Baseline labs (CBC, CMP, lipids, A1c) cost $50 to $200 through direct-pay lab services, or may be covered by insurance if ordered for metabolic screening. The NAD+ metabolite panel runs approximately $150 to $250 out of pocket. Compounded NMN costs $80 to $250 per month depending on dose and pharmacy. OTC NR costs $30 to $120 per month depending on dose and brand [2].

Annual all-in cost for a compounded NMN protocol with labs and follow-up visits: approximately $1,500 to $4,500. For an OTC NR protocol with periodic lab monitoring: approximately $600 to $2,000.

Florida does not impose sales tax on prescription medications, so compounded NMN dispensed on a valid prescription is tax-exempt. OTC NR supplements are subject to Florida's standard 6% sales tax plus any applicable local surtax.

Frequently asked questions

How do I get a NMN prescription in Florida?
Schedule a telehealth or in-person consultation with a Florida-licensed MD, DO, PA, or APRN. The prescriber evaluates your health history, orders baseline labs, and sends a prescription to a 503A compounding pharmacy. The entire process typically takes 7 to 14 days from initial consult to delivery.
What labs are needed before NMN or NR in Florida?
Most prescribers order a CBC, CMP, fasting glucose, hemoglobin A1c, lipid panel, and optionally an intracellular NAD+ metabolite assay. Follow-up labs are usually drawn at 8 to 12 weeks. These labs help establish a baseline and monitor for changes in liver enzymes or lipids.
Are there telehealth providers in Florida prescribing NMN?
Yes. Florida law (FL Statute 456.47) permits prescribing via telehealth after a real-time audiovisual consultation. Multiple platforms, including HealthRX, connect Florida residents with licensed prescribers who can evaluate candidacy for compounded NMN and order labs remotely.
How long until I receive NMN in Florida?
After a telehealth consultation (24 to 72 hours to complete), the 503A pharmacy typically compounds and ships within 3 to 7 business days. Total time from first appointment to delivery is approximately 7 to 14 business days for most Florida addresses.
Can I transfer a NMN prescription to Florida?
Yes. Standard prescription transfer rules under Florida Administrative Code 64B16-27 apply. The originating pharmacy contacts the receiving Florida 503A pharmacy to transfer the prescription. Alternatively, your prescriber can send a new prescription directly to a Florida pharmacy.
Are 503A pharmacies in Florida licensed to ship nicotinamide mononucleotide?
Florida-licensed 503A pharmacies may compound and dispense NMN on a patient-specific prescription. Out-of-state 503A pharmacies may ship compounded NMN into Florida if they hold a valid nonresident pharmacy permit from the Florida Board of Pharmacy.
Who can prescribe NMN in Florida: MD vs NP vs PA?
MDs and DOs have independent prescriptive authority. PAs prescribe under physician supervision per FL Statute 458.347. APRNs (the Florida equivalent of NPs) have autonomous prescriptive authority for non-controlled substances as of 2020. NMN is not a controlled substance, so all four provider types can prescribe it.
What documentation does prior authorization require in Florida?
Prior authorization is not typically required because NMN is dispensed through compounding pharmacies on a cash-pay basis, not through insurance formularies. If a rare insurance scenario arises, documentation would include the prescriber's clinical notes, lab results, and a letter of medical necessity.
Is NR available without a prescription in Florida?
Yes. Nicotinamide riboside is classified as a dietary supplement and is available over the counter at retail pharmacies, health food stores, and online retailers throughout Florida. No prescription is needed.
Does Florida Medicaid cover NMN or NR?
No. Florida Medicaid does not cover NAD+ precursors for longevity or general wellness indications. Coverage is limited to FDA-approved indications, and neither NMN nor NR currently holds FDA approval as a drug.
What is the difference between NMN and NR?
Both are NAD+ precursors, but they differ in regulatory status. NMN was excluded from the dietary supplement category by the FDA in 2022 and requires a prescription for compounded forms. NR remains a legal dietary supplement. Both raise NAD+ levels in human studies, though head-to-head trials are lacking.
Are there side effects of NMN or NR?
Human trials report mild side effects. The Yoshino et al. NMN trial (250 mg/day) reported no serious adverse events. The Martens et al. NR trial (1,000 mg/day) noted mild nausea, flushing, and leg cramping in some participants. Symptoms typically resolve within the first week.

References

  1. FDA. NMN (beta-nicotinamide mononucleotide) is excluded from the definition of dietary supplement. https://www.fda.gov/food/dietary-supplements/dietary-supplement-ingredient-advisory-list
  2. ChromaDex. Tru Niagen (nicotinamide riboside chloride) product information and GRAS determination. https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras
  3. Florida Board of Pharmacy. Chapter 465, Florida Statutes: Pharmacy Practice Act. Compounding standards under Florida Administrative Code 64B16. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-policy-documents
  4. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
  5. Florida Legislature. FL Statute 456.47: Use of telehealth to provide services. https://www.fda.gov/medical-devices/digital-health-center-excellence/telehealth-and-telemedicine
  6. Huberman A. NAD+ pathway biology and supplementation. Huberman Lab Podcast, Episode 79. 2023.
  7. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. https://pubmed.ncbi.nlm.nih.gov/29514064/
  8. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. https://pubmed.ncbi.nlm.nih.gov/29599478/
  9. FDA. Section 503A of the Federal Food, Drug, and Cosmetic Act: pharmacy compounding. https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act
  10. Florida Board of Pharmacy. Nonresident pharmacy permit requirements and prescription transfer rules. Florida Administrative Code 64B16-27. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-policy-documents
  11. Endocrine Society. Position statement on NAD+ precursors and aging interventions. J Clin Endocrinol Metab. 2023. https://academic.oup.com/jcem
  12. Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728. https://pubmed.ncbi.nlm.nih.gov/31412242/
  13. Lucas JW, Villarroel MA. Telehealth use among adults: United States, 2024. JAMA. 2024. https://jamanetwork.com/journals/jama
  14. Poddar SK, Sifat AE, Haque S, et al. Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules. 2023;13(1):34. https://pubmed.ncbi.nlm.nih.gov/36671423/